Compounds > dobutamine
Page last updated: 2024-08-23

dobutamine and Mitochondrial Diseases

dobutamine has been researched along with Mitochondrial Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdullah, CS; Aishwarya, R; Alam, S; Bhuiyan, MAN; Bhuiyan, MS; James, J; Lorenz, JN; Miriyala, S; Orr, AW; Osinska, H; Panchatcharam, M; Peretik, JM; Robbins, J1
Garcia-Menendez, L; Gong, G; Karamanlidis, G; Kolwicz, SC; Lee, CF; Morgan, PG; Sedensky, MM; Suthammarak, W; Tian, R; Wang, W1
Barzaghi, P; Buyse, GM; Courdier-Fruh, I; D'hooge, J; Erb, M; Herijgers, P; Jara, A; Meier, T; Mertens, L; Van Den Bergh, A; Van der Mieren, G; Verbeken, E1

Other Studies

3 other study(ies) available for dobutamine and Mitochondrial Diseases

ArticleYear
Cardiac Dysfunction in the Sigma 1 Receptor Knockout Mouse Associated With Impaired Mitochondrial Dynamics and Bioenergetics.
    Journal of the American Heart Association, 2018, 10-16, Volume: 7, Issue:20

    Topics: Adenosine Triphosphate; Adrenergic beta-1 Receptor Agonists; Animals; Biomarkers; Cell Respiration; Dobutamine; Echocardiography; Electron Transport; Energy Metabolism; Female; Fibrosis; Heart Diseases; Hemodynamics; Male; Mice, Knockout; Microscopy, Electron, Transmission; Mitochondria, Heart; Mitochondrial Diseases; Mitochondrial Dynamics; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Oxygen Consumption; Receptors, sigma; Sigma-1 Receptor

2018
Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.
    Cell metabolism, 2013, Aug-06, Volume: 18, Issue:2

    Topics: Acetylation; Animals; Cardiotonic Agents; Dobutamine; Electron Transport Complex I; Female; Heart Failure; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitochondrial Diseases; Myocardium; NAD; Oxidative Stress; Pregnancy; Reactive Oxygen Species; Sirtuin 3

2013
Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance.
    European heart journal, 2009, Volume: 30, Issue:1

    Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Diastole; Dobutamine; Echocardiography; Fibrosis; Male; Mice; Mice, Inbred mdx; Mitochondrial Diseases; Muscle, Skeletal; Muscular Dystrophy, Animal; Myocardium; Oxidative Stress; Physical Conditioning, Animal; Placebos; Single-Blind Method; Time Factors; Troponin I; Ubiquinone

2009